Monitoring Renal Transplant Rejection: Non-Invasive Advances
Received Date: Jan 02, 2025 / Published Date: Jan 30, 2025
Abstract
This research synthesizes findings on kidney transplant rejection monitoring, emphasizing non-invasive biomarkers like ddcfDNA and GEP for early detection and personalized treatment. It reviews antibody-mediated rejection (AMR), chronic active AMR, and diagnostic tools including AI in pathology and DSA monitoring. Urinary biomarkers and miRNAs are explored for their non-invasive potential. The data suggests that advanced non-invasive methods complement traditional biopsies, improving graft surveillance and management
Keywords: Renal Transplant Rejection脥戮 Non-Invasive Monitoring脥戮 Donor- Derived Cell-Free DNA脥戮 Gene Expression Profiling脥戮 Antibody- Mediated Rejection脥戮 Donor-Specific Antibodies脥戮 Urinary Biomarkers脥戮 MicroRNAs脥戮 Artificial Intelligence
Citation: Iyer R (2025) Monitoring Renal Transplant Rejection: Non-Invasive Advances. J Clin Exp Transplant 10: 267 Doi: 10.4172/2475-7640.1000267
Copyright: © 2025 Ramesh Iyer This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 138
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 107
- PDF downloads: 31
